Teligent, Inc. Business Finance Contracts & Agreements
41 Contracts & Agreements
- Credit Agreements (15 contracts)
- Exchange Agreements (6)
- Guaranty Agreements (1)
- Indenture Agreements (5)
- Loan Agreements (2)
- Note Agreements (1)
- Purchase Agreements (5)
- Stock Agreements (3)
- Underwriting Agreements (1)
- Warrant Agreements (2)
- Description of Capital Stock (Filed With SEC on May 4, 2021)
- Amendment No. 6 to Second Lien Credit Agreement, dated as of January 27, 2021, by and among the Company, its subsidiaries signatory thereto, the lenders party thereto, and Ares... (Filed With SEC on January 28, 2021)
- Exchange Agreement, dated as of January 27, 2021, by and among the Company, certain funds and accounts managed by affiliates of Ares Management Corporation, and the Participating... (Filed With SEC on January 28, 2021)
- Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock dated January 25, 2021 (Filed With SEC on January 28, 2021)
- Form of Series B Exchange Agreement, dated as of September 22, 2020, between the Company and the exchanging holder of Series B Convertible Notes party thereto (Filed With SEC on September 23, 2020)
- Form of Series A Exchange Agreement, dated as of September 22, 2020, between the Company and the exchanging holders of Series A Convertible Notes party thereto (Filed With SEC on September 23, 2020)
- Indenture, dated as of September 22, 2020, by and between the Company and Wilmington Savings Fund Society, FSB, as Trustee (Filed With SEC on September 23, 2020)
- Consent and Amendment No. 3 to First Lien Credit Agreement, dated as of July 20, 2020, by and among the Company, its subsidiaries signatory thereto, the lenders party thereto, and... (Filed With SEC on July 20, 2020)
- Exchange Agreement, dated as of July 20, 2020, between the Company, certain of its subsidiaries and the exchanging holders of Series B Convertible Notes party thereto (Filed With SEC on July 20, 2020)
- Exchange Agreement, dated as of July 20, 2020, between the Company, certain of its subsidiaries and the exchanging holders of Series A Convertible Notes party thereto (Filed With SEC on July 20, 2020)
- Form of Purchase Agreement, dated as of July 20, 2020, between the Company, certain of its subsidiaries and the purchasers party thereto (Filed With SEC on July 20, 2020)
- Form of Warrant, dated July 20, 2020, by and among the Company and the lenders party thereto (Filed With SEC on July 20, 2020)
- Indenture, dated as of July 20, 2020, by and among the Company, the Subsidiary Guarantors named therein, and Wilmington Trust, National Association, as Trustee and Collateral Agent (Filed With SEC on July 20, 2020)
- Amendment No. 2 dated July 18, 2019 to Second Lien Credit Agreement dated December 31, 2018 by and among the Company, certain subsidiaries, the lenders from time to time party... (Filed With SEC on April 13, 2020)
- Amendment No. 1 dated February 8, 2018 to Second Lien Credit Agreement dated December 31, 2018 by and among the Company, certain subsidiaries, the lenders from time to time party... (Filed With SEC on April 13, 2020)
- Description of Capital Stock (Filed With SEC on April 13, 2020)
- Amendment No. 4 to Second Lien Credit Agreement, dated as of April 6, 2020 by and among the Company, its subsidiaries signatory thereto, the lenders party thereto, and Ares... (Filed With SEC on April 8, 2020)
- Amendment No. 2 to First Lien Credit Agreement, dated as of April 6, 2020, by and among the Company, its subsidiaries signatory thereto, the lenders party thereto, and ACF Finco I... (Filed With SEC on April 8, 2020)
- Form of Warrant, dated as of April 6, 2020, by and among the Company and the lenders party thereto (Filed With SEC on April 8, 2020)
- Indenture, dated as of October 31, 2019, by and among the Company, the Subsidiary Guarantors named therein, and Wilmington Trust, National Association, as Trustee (Filed With SEC on October 31, 2019)
- Consent and Amendment No. 3 to Second Lien Credit Agreement, dated as of October 31, 2019, by and among the Company, its subsidiaries signatory thereto, the lenders party thereto,... (Filed With SEC on October 31, 2019)
- Consent and Amendment No. 1 to First Lien Credit Agreement, dated as of October 31, 2019, by and among the Company, its subsidiaries signatory thereto, the lenders party thereto,... (Filed With SEC on October 31, 2019)
- Form of Exchange Agreement, dated as of October 28, 2019, between the Company and the exchanging noteholder party thereto (Filed With SEC on October 31, 2019)
- Form of Purchase Agreement, dated as of October 28, 2019, between the Company and the purchaser party thereto (Filed With SEC on October 31, 2019)
- Second Lien Credit Agreement, dated as of December 13, 2018, by and among Teligent, Inc., as Borrower, certain Subsidiaries thereof, as Guarantors, the Lenders from time to time... (Filed With SEC on December 14, 2018)
- First Lien Revolving Credit Agreement, dated as of December 13, 2018, by and among Teligent, Inc., as Borrower, certain Subsidiaries thereof, as Guarantors, the Lenders from time... (Filed With SEC on December 14, 2018)
- Credit Agreement, dated June 1, 2018, by and among Teligent, Inc., the guarantors party thereto from time to time, each lender from time to time party thereto and Cantor... (Filed With SEC on June 5, 2018)
- Indenture, by and between the Company and Wilmington Trust, National Association, as trustee, dated May 1, 2018 (Filed With SEC on May 2, 2018)
- FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (Filed With SEC on December 4, 2015)
- Intra-Group Loan Agreement between Teligent Canada Inc. as Borrower and Teligent, Inc. as Lender White & Case LLP5 Old Broad Street London EC2N 1DW (Filed With SEC on November 16, 2015)
- Intra-Group Loan Agreement between Teligent Luxembourg S.à r.l as Borrower and Teligent, Inc. as Lender White & Case LLP 5 Old Broad Street London EC2N 1DW (Filed With SEC on November 16, 2015)
- ASSET PURCHASE AGREEMENT among CONCORDIA PHARMACEUTICALS INC., S.À.R.L.,BARBADOS BRANCH, TELIGENT JERSEY LIMITED and IGI LABORATORIES, INC. DATED AS OF OCTOBER 5, 2015 (Filed With SEC on November 9, 2015)
- THIRD AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on November 9, 2015)
- SECOND AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on November 9, 2015)
- IGI Laboratories, Inc. $125,000,000 3.75% Convertible Senior Notes due 2019 PURCHASE AGREEMENT (Filed With SEC on December 17, 2014)
- IGI Laboratories, Inc. (Company) WilmingtonTrust, National Association (Trustee) 3.75%Convertible Senior Notes due 2019 INDENTURE Datedas of December 16, 2014 (Filed With SEC on December 17, 2014)
- FIRST AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on December 9, 2014)
- GUARANTY AND SECURITYAGREEMENT Dated as of November 18,2014 by IGI LABORATORIES, INC.,IGEN, INC. and IGI LABS, INC., as Borrowers, and EACH OTHER GRANTOR FROM TIME TO TIME... (Filed With SEC on November 24, 2014)
- CREDIT AGREEMENT Dated as of November 18, 2014 by and among IGI LABORATORIES, INC., IGEN INC. andIGI LABS, INC., as the Borrowers, THE OTHER PERSONS PARTY HERETO THATARE... (Filed With SEC on November 24, 2014)
- ASSET PURCHASE AGREEMENT By and between AstraZeneca Pharmaceuticals LP and IGI Laboratories, Inc. Dated as of September 24, 2014 (Filed With SEC on November 13, 2014)
